RxDoctor Payments Data

Nicholas Delaney, MD

Orthopaedic Surgery · Albany, NYNPI 1558596114

Payments from drug & device makers

$30,509in general payments, 2019–2025

Across 64 payments — averaging $476.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lazurite Inc.$22K
  • Seapearl East, Inc$6K
  • Arthrex$1K
  • Johnson & Johnson$396
  • Stryker$202
  • Zimmer Biomet$150
  • plus $265 from 10 others

What the payments were for

  • Travel & lodging$2,22328%
  • Food & beverage$1,93124%
  • Education$3,91649%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lazurite Inc.4$22,440
Seapearl East, Inc16$5,942
Arthrex15$1,114
Johnson & Johnson11$396
Stryker2$202
Zimmer Biomet2$150
ERMI LLC1$41
Electronic Waveform Lab, Inc.2$40
Fidia Pharma USA Inc.2$35
Sanofi-aventis U.S. LLC2$29
Amgen2$27
Ossur Americas, Inc.1$24
Avanos Medical1$21
Orthogenrx Inc.1$17
Ferring Pharmaceuticals Inc.1$15
Vertos Medical, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,509 in reported general payments places this provider in the 75th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$37,792
Medicare patients
68
Services billed
376

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam40$106

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Albany

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →